Plain Votes

U.S. House · 118th Congress · H.R. 3810

Drug Origin Transparency Act of 2023

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Anna G. EshooD-CA-16
Introduced
June 5, 2023, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (4)

4 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these

Signed on later